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Abstract
Background: Penicillium marneffei is the only dimorphic member of the genus and is an emerging pathogenic
fungus that can cause fatal systemic mycosis. Penicillium marneffei disseminates hematogenously to other locations.
Penicillium marneffei infection most commonly involves the skin, lungs, and reticuloendothelial system, including
the bone, bone marrow, joints, lymph nodes, pericardium, liver, and spleen. Involvement of the mesenteric and
central nervous systems has also been reported. Infection involving the trachea has not been previously reported.
Case presentation: We herein report a previously healthy 28-year-old male farmer from Guangxi Province without
HIV who became infected with P. marneffei. The infection primarily affected the trachea, resulting in structural damage
to the cartilage, tracheal stenosis, and tracheal absence. The infection also involved the lungs and lymph nodes. After
antifungal treatment and surgery, his symptoms, signs, and lung imaging findings showed significant improvement.
This is the first such case report.
Conclusion: Penicillium marneffei infection in normal hosts is characterized by an insidious onset, various clinical
manifestations, and common misdiagnosis, leading to high mortality rates. Penicillium marneffei hematogenously
disseminates throughout the whole body. This is the first reported case of P. marneffei infection involving the main
trachea with subsequent structural damage to the tracheal cartilage, severe tracheostenosis, and tracheal absence.
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Background
Penicillium marneffei (PM) is a facultative intracellular
pathogen that is capable of causing disseminated infection
in both humans and wild bamboo rats. PM has been
widely described in patients with HIV/AIDS as well as in
other hosts, especially those with cellular immune defects
[1]. Common clinical manifestations of PM infection are
fever, weight loss, anemia, lymphadenopathy, hepatosple-
nomegaly, respiratory signs, and skin lesions [1,2]. PM
infection most commonly involves the skin, lungs, and the
reticuloendothelial system, including the bone, bone
marrow, joints, lymph nodes, pericardium, liver, and
spleen. Involvement of the mesenteric and central nervous
systems has also been reported [1-3]. We herein report a
case involving a 28-year-old man without HIV who devel-
oped a disseminated PM infection involving the main
trachea. The infection resulted in structural damage to the
tracheal cartilage, severe tracheostenosis, and up to 2 cm
of tracheal absence. This is the first such case reported
worldwide.
Case presentation
A previously healthy 28-year-old male farmer from
Guangxi Province, China was admitted to a local hospital
because of blurred vision, numbness of the limbs, an
intermittent fever, coughing, and sputum production in
May 2012 after having killed several bamboo rats a few
days previously. High-resolution computed tomography
(HRCT) of the chest showed plaques, nodules, and exud-
ation disseminated throughout both lung fields, especially
the upper lung (Figure 1). A sputum smear, sputum
culture, and cerebrospinal fluid culture were negative.
Tuberculosis and neuromyelitis optica was confirmed as a
clinical diagnosis according to the characteristic imaging
findings and clinical manifestations. The tuberculosis was
treated with isoniazid, rifampicin, pyrazinamide, and eth-
ambutol, and the neuromyelitis optica was treated with
prednisone (50 mg daily with gradual tapering until
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discontinuation). Three months later, his vision recovered
and his numbness disappeared; however, his respiratory
signs deteriorated. Post-treatment chest HRCT showed
that the lesions were larger than their pretreatment size,
and a cavity was found in the left upper lung field
(Figure 2). A further 3 months later, the patient developed
hoarseness accompanied by a sore throat. Laryngoscopy
showed pharyngitis, but the patient did not respond to a
2-week course of antibiotics and his condition worsened.
He was referred to our hospital on 16 April 2013. Laryn-
goscopy showed laryngeal and pharyngeal ulcers that were
suggestive of laryngeal tuberculosis. Chest HRCT showed
that the lung lesions had worsened and that protrusions on
the upper tracheal wall had developed (Figures 3, 4 and 5).
Bronchoscopy revealed unevenness of the trachea in
the subglottic region and protrusions on the tracheal wall
(Figure 6). Therefore, the antituberculosis treatment was
continued with the addition of intratracheal instillation.
Pathological examination of the protrusions on the tracheal
wall showed atypical granulomas and microabscesses, but
acid-fast staining results were negative. Periodic acid-Schiff
staining revealed aggregates of macrophages that were
engorged with numerous yeast-like organisms, 3 to 8 μm in
diameter. These yeast-like organisms were spherical to oval
and had a transverse septum (Figure 7). After 1 week, PM
was isolated from a bronchoalveolar lavage fluid sample,
and the tracheal protrusions were cultured (Figure 8a,b).
The final diagnosis was disseminated PM infection involving
Figure 1 Chest HRCT showed plaques and exudation disseminated
throughout both lung fields, especially the upper lung.
Figure 2 Chest HRCT showed that the lesions had grown in
size and that a cavity was present in the left upper lung.
Figure 3 Chest HRCT showed that the lung lesions had worsened
and that protrusions were present on the tracheal wall.
Figure 4 Chest HRCT showed that the lung lesions had worsened
and that protrusions were present on the tracheal wall.
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the lungs, laryngeal tissue, mediastinal lymph nodes, and
trachea. The antituberculosis treatment was changed to
intravenous amphotericin B at an initial dose of 0.3 mg/kg
daily with a gradual increase to 0.6 mg/kg daily as well as
oral itraconazole at 200 mg twice daily. Two weeks later, the
patient’s signs and symptoms were obviously improved;
thus, only the itraconazole was continued, and the patient
was discharged. Ten days later, he was referred to our emer-
gency department because of severe dyspnea. Chest HRCT
showed lower tracheal stenosis (Figure 9). Endotracheal
intubation and tracheotomy were immediately performed.
He was discharged after 1 week. Two months later, he was
admitted again to our hospital because of the development
of tracheostenosis.
Physical examination revealed weight loss and a body
temperature of 37.3°C. The chest, abdomen, superficial
lymph nodes, and skin were normal. Chest HRCT showed
a proximal tracheal occlusion, lower tracheal stenosis, and
obvious absorption of the lesion compared with the previ-
ous HRCT (Figure 10). Laryngoscopy showed tracheal
occlusion between the subglottic trachea and tracheal in-
cision previously created for maintenance of respiration.
Routine blood examination revealed a leukocyte count of
5.34 × 10−9/L, neutrophil percentage of 47.4%, and hemog
lobin level of 116 g/L. His serum albumin level was
39.3 g/L. His CD4 T-cell count was 370/μL, C-reactive
protein level was >200 mg/L, and erythrocyte sedimenta-
tion rate was 41 mm/h. His plasma beta-D-glucan meas-
urement was high, but his galactomannan test results,
aspartate aminotransferase level, alanine aminotransferase
level, and creatinine level were all normal. He was nega-
tive for antistreptolysin O, antinuclear antibody, and
rheumatoid factor. Blood and tissue microbiological
cultures and HIV testing of blood samples were negative.
These tests were repeated several times to ensure the reli-
ability of the results.
Surgery was planned to treat the tracheal occlusion.
During the surgery, we found tracheal collapse secondary
to structural damage to the cartilage of the lower tracheal
segment, as well as tracheal absence between the tracheal
occlusion and tracheal incision (Figure 11). Specimens of
the surrounding tissue were obtained for pathologic exam-
ination and culture. Tracheoplasty was converted to
tracheal sleeve resection, tracheal cricoid anastomosis,
and tracheostomy. The patient’s tracheal cannula was
maintained to allow for breathing. The surrounding tissue
cultures were negative. Pathological examination with
periodic acid-Schiff, methenamine silver, and acid-fast
staining was negative. The patient reported no postopera-
tive dyspnea due to blocking of the tracheal stoma. The
itraconazole was continued. The patient returned for
follow-up 1 week postoperatively. His CD4 T-cell count
had recovered to 745/μL, and his CD8 T-cell count was
412/μL. Chest HRCT showed that the trachea was unob-
structed and that the tracheostenosis and lesions had
significantly improved (Figures 12 and 13).
Conclusions
PM disseminates hematogenously to other locations [1,2].
The reticuloendothelial system, skin, and lungs are the
most commonly involved sites. PM can disseminate into
the bone, bone marrow, joints, lymph nodes, pericardium,
liver, spleen, mesenteric tissue, and even the central ner-
vous system [1-3]. Healthy hosts infected with PM present
with various symptoms. Patients with severe systemic in-
flammatory response manifests as fever, obvious increases
in leukocyte and neutrophil counts, a high erythrocyte
sedimentation rate, and a high C-reactive protein level.
Moreover, weight loss, anemia, severe hypoproteinemia,
and even multiple organ failure have been reported [4-6].
Figure 5 Chest HRCT showed that the lung lesions had worsened
and that protrusions were present on the tracheal wall.
Figure 6 Bronchoscopy showed unevenness of the subglottic
trachea and the presence of protrusions on the tracheal wall.
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In this paper, we reported a case involving a healthy host
without HIV or other underlying diseases who developed
disseminated PM infection. Tests for antistreptolysin O,
antinuclear antibody, rheumatoid factor, and HIV were
negative. We found no possible causes of immunodefi-
ciency. Although rare, PM has been reported in healthy
hosts [4]. However, the present patient had risk factors for
infection: he was living in an endemic area and had a
history of contact with bamboo rats. After 5 months of
antifungal treatment, his CD4 T-cell level recovered, indi-
cating that he was not initially immunodeficient. PM
grows as yeast bodies inside phagocytes. Immunosuppres-
sion after infection is a commonly encountered problem
in affected patients. Causes of immune depletion may
include prednisolone therapy, initial misdiagnosis, and dis-
ease progression.
The patient described herein exhibited symptoms dif-
ferent from those previously reported in the literature.
His systemic inflammatory response was mild. The pa-
tient was misdiagnosed with tuberculosis as a clinical
diagnosis because the lung imaging changes, symptoms,
and protrusions on the tracheal wall were very similar to
the characteristics of tuberculosis, which is a common
disease in China. The long duration of misdiagnosis and
mistreatment accelerated the progression of the disease,
resulting in structural damage to the tracheal cartilage,
tracheostenosis, and a tracheal absence of up to 2 cm.
This is the first case of such developments in a patient
with PM infection. Humans infected with PM can show
three pathological patterns: suppuration, granuloma for-
mation, or anergy with necrosis. The first and second
patterns are more commonly seen in healthy hosts [7].
Because of the long duration of misdiagnosis of TB and
prednisolone therapy in the present case, the PM infection
Figure 7 The pathological examination results of the tracheal protrusions showed macrophages that were engorged with numerous
yeast-like organisms 3 to 8 μm in diameter. These yeast-like organisms were spherical to oval and had a transverse septum shown by the
arrows a and b (period acid-Schiff staining, 400×).
Figure 8 (a) Bronchoalveolar lavage fluid and culture of the
tracheal wall protrusions. Penicillium marneffei grows as a yeast at
37°C on Sabouraud dextrose agar but as a mold at 25°C on the
same agar, exhibiting a soluble red pigment that diffuses into the
medium. (b) The yeast form of P. marneffei has a characteristic
morphology, including sausage-shaped yeast bodies shown by the
arrow C.
Figure 9 Chest HRCT showed a proximal tracheal occlusion,
lower tracheal stenosis, and obvious absorption of the lesion.
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involved the main trachea and subsequently resulted in
severe tracheostenosis and tracheal absence. PM infection
can result in the accumulation of massive numbers of neu-
trophils and the release of proteolytic enzymes in a local
inflammatory response, causing tissue dissolution, suppur-
ation, necrosis, and fibroplasia. These changes cause struc-
tural damage to the tracheal cartilage and cicatricial
reparation, resulting in tracheal collapse, severe tracheoste-
nosis, and tracheal absence.
PM infection is associated with high mortality because
it is commonly misdiagnosed in the early stages [8,9].
PM is identified by culture, pathological examination,
Figure 10 Lower segment tracheal collapse and tracheal absence
of up to 2 cm between the tracheal occlusion and tracheal incision.
Figure 11 After treatment, the trachea was unobstructed and the
lower tracheal stenosis and lesions showed significant improvement.
Figure 12 After treatment, the lower tracheal stenosis and
lesions showed significant improvement.
Figure 13 After treatment, the trachea was unobstructed.
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and cytological analysis [10]. PM grows as a yeast at 37°C,
but as a mold at 25°C on Sabouraud dextrose agar, exhibit-
ing a soluble red pigment that diffuses into the medium
[1,8]. The yeast form of PM has a characteristic morph-
ology, including a transverse septum and sausage-shaped
organisms that can be demonstrated by pathological and
cytological examination [8,10].
The differential diagnoses for PM include tuberculosis,
histoplasmosis, lymphoma, cryptococcosis, panniculitis,
molluscum contagiosum, and various other viral infec-
tions [8,10]. Tuberculosis is the most common misdiag-
nosis for the following reasons: (i) relevant literature and
research on PM are limited; (ii) PM has been strongly
emphasized as a common opportunistic infection of pa-
tients with AIDS; (iii) the signs, lung imaging findings,
and pathological examination results are similar to
those of tuberculosis; and (iv) in the early stages, there is a
low concentration of viable lesions and a low culture-
positive rate.
Penicilliosis is very susceptible to antifungal treatment.
PM is susceptible to itraconazole and amphotericin B
in vitro [11,12]. The current recommendation for patients
with HIV infection is amphotericin B at a dosage of
0.6 mg/kg daily for 2 weeks, followed by oral itraconazole
at a dosage of 200 mg twice daily for 10 weeks [11]. After
24 weeks of regular antifungal therapy and surgery, the
symptoms, signs, and lung imaging findings of the present
patient showed significant improvements.
PM infection in normal hosts is characterized by an
insidious onset, various clinical manifestations, and com-
mon misdiagnosis, leading to high mortality rates. PM dis-
seminates throughout the whole body via a hematogenous
route. This PM infection involving the main trachea with
subsequent structural damage to the tracheal cartilage,
severe tracheostenosis, and tracheal absence is the first
such reported case. The patient had a good response to
antifungal treatment, but mild tracheostenosis remained
after surgery. PM infection is characterized by a high rate
of recurrence. Therefore, this patient will require a long
follow-up duration to evaluate the long-term effects of the
infection. There is no generally recognized treatment that
is effective for PM infection in patients without HIV. The
recommended treatment for healthy hosts requires further
investigation.
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